Federica Albanese

I completed my Master Degree in Pharmaceutical Chemistry from University of Ferrara, Italy in 2018. Then, I started my Ph.D. in Neuroscience studying the interplay between LRRK2 and autophagy in vivo. I graduated in January 2022 and right after, I joined the Kalia lab to investigate the mechanism through which molecular chaperones contribute to neurodegeneration in Parkinson’s Disease.

Jimmy George

I completed my BSc in Biotechnology from Bangalore University, India in 2009, followed by my Master’s in Molecular Medicine from University of Sheffield, UK in 2010. After this I went on to do my Ph.D. in Experimental Biology and Neuroscience from the University of Coimbra, Portugal, and University of Bordeaux, France, where I worked in deciphering the interaction of Purines with Neuron-Glia in Neuroinflammation. My first postdoctoral fellowship was at Northwestern University, US, unravelling the role of autophagy in neurodegeneration. I joined the Kalia lab in 2021 to be part of their ongoing research to uncover the molecular and cellular mechanisms of neurodegeneration in Parkinson’s Disease.

Minesh Kapadia

I received my BHSc from McMaster University in 2010. I subsequently pursued a PhD in Neuroscience focusing on characterizing the role of brain-reactive autoantibodies in a model of neuropsychiatric lupus in Dr. Boris Sakic’s lab. I graduated in November 2015 and began a postdoctoral fellowship with Dr. Margaret Fahnestock, coordinating a collaborative project examining epigenetic factors and immune mechanisms underlying sex differences in behaviour and pathology in a mouse model of Alzheimer’s disease. I joined the Kalia labs in 2018 and my current research focuses on characterizing the molecular chaperone pathways involved in Parkinson’s disease.